Article info
Clinical science
Characterisation of the vascular anterior surface of type 1 macular neovascularisation after anti-VEGF therapy
- Correspondence to Dr SriniVas Sadda, Doheny Image Reading Center, Doheny Eye Institute Doheny Image Reading Center, Los Angeles, California, USA; ssadda{at}doheny.org
Citation
Characterisation of the vascular anterior surface of type 1 macular neovascularisation after anti-VEGF therapy
Publication history
- Received July 13, 2021
- Accepted April 25, 2022
- First published May 10, 2022.
Online issue publication
October 18, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.